查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829818

2025年全球粘膜给药装置市场报告

Transmucosal Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，经粘膜给药装置市场规模强劲成长，从2024年的502.4亿美元增加至2025年的546.3亿美元，复合年增长率为8.7%。这段历史时期的成长可归因于快速缓解心绞痛的需求、舌下给药快速吸收进入血液的有效性、避免胃肠道劣化的需求、颊片的开发以及对胜肽和蛋白质非侵入性递送的需求。

预计未来几年，粘膜给药装置市场规模将强劲成长，到2029年将达到760.6亿美元，年复合成长率（CAGR）为8.6%。预测期内的成长可归因于智慧给药系统的发展、慢性病发病率的上升、对个人化医疗的日益重视、高用药需求的老龄化人口以及人们日益增强的医疗意识。预测期内的主要趋势包括：治疗应用的扩展、个人化医疗给药装置的客製化、监管批准和指南的製定、新兴市场、环保装置以及创新配方。

粘膜给药装置是医疗设备，旨在透过口腔、鼻腔或直肠等黏膜给药，使其快速吸收进入血液。这类装置尤其适用于输送胃肠道吸收不良或需要快速起效的药物，例如止痛药或荷尔蒙疗法。其主要功能是绕过消化器官系统，提供直接有效的给药途径。

粘膜给药装置主要分为两类：粘膜和主动式。被动式粘膜给药是指药物无需外部能量或主动转运机制即可经由粘膜吸收。产品类型包括颊片、口腔喷雾、舌下膜、薄片、凝胶和糖果甜点，用于疼痛管理、成瘾治疗和荷尔蒙疗法等。最终用户包括学术和研究机构、製药和生物技术公司、诊断实验室以及医院。

2025年春季，美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战进一步加剧了形势，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场准入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，粘膜系列提供粘膜给药装置市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的粘膜粘膜装置细分市场、市场趋势、商业机会以及在粘膜给药装置行业取得成功所需的其他数据。本粘膜给药装置市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年8.6%的预测成长率，较我们先前对该市场的预测略有下降0.6%。下降主要源自于美国与其他国家之间关税的影响。这可能会直接影响美国，导致来自比利时和加拿大等主要地区的生物黏附聚合物薄膜和精密计量泵的供应链中断，从而可能导致速效给药系统短缺。此外，由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，其影响也将更加广泛。

预计未来几年慢性病盛行率的上升将推动粘膜给药装置市场的成长。慢性病通常发展缓慢，持续时间长，通常需要持续的医疗管理来控制症状和预防併发症。慢性病的增加归因于生活方式的选择、人口老化、环境影响、医疗保健系统内部的挑战、都市化等因素。粘膜给药装置透过提供可控且高效的药物输送来管理慢性病，确保持续的治疗水平以控制症状并提高患者依从性。例如，根据美国非营利组织白血病和淋巴瘤协会 (LLS) 2023 年 8 月的报告，美国大约每三分钟就会有一人被诊断出患有白血病、淋巴瘤或骨髓瘤。预计 2023 年将诊断出 184,720 例病例，占当年 1,958,310 例新发癌症病例的 9.4%。因此，慢性病盛行率的上升正在推动粘膜给药装置市场的成长。

经粘膜给药装置领域的主要企业正在积极寻求创新解决方案，例如专有的经皮吸收贴片给药平台，旨在改善药物吸收、增强患者依从性并提供便利性。这些平台利用各自公司的专长技术，透过皮肤给药，实现控制释放并优化治疗效果。例如，2024年1月，美国生物技术公司Starton Therapeutics Inc.推出了一款名为STARSILON的全新专有经皮吸收贴片给药平台。该平台专门设计用于长时间递送难以配製的活性药物成分（API），从而扩展了经皮给药的选择，并透过其缓释性机制增强治疗效果。

2023年4月，印度製药公司Diffgen Pharmaceuticals收购了Aveva Drug Delivery Services，收购金额未揭露。此次策略性收购旨在增强Diffgen Pharmaceuticals的药物输送能力，并为其药品组合注入先进技术。总部位于美国的Aveva Drug Delivery Services专注于生产经皮剂型(TDS)和口腔溶解膜(ODF)。

粘膜给药装置市场包括舌下喷雾、滴鼻剂、直肠栓剂和舌下片剂的销售。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球粘膜给药装置：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球粘膜给药装置市场：成长率分析
  • 全球粘膜给药装置市场表现：规模与成长，2019-2024
  • 全球粘膜给药装置市场预测：规模与成长，2024-2029年，2034年
  • 全球粘膜给药装置：总目标市场（TAM）

第六章 市场细分

  • 全球粘膜给药装置市场类型、表现及预测（2019-2024、2024-2029、2034）
  • 被动经经皮给药
  • 主动经皮给药
  • 全球粘膜给药装置市场（依药物类型、表现及预测），2019-2024 年、2024-2029 年、2034 年
  • 颊片
  • 口腔喷雾剂
  • 舌下膜和舌下薄片
  • 凝胶
  • 药用糖果甜点
  • 其他药物类型
  • 全球粘膜给药装置市场（依适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 成瘾治疗
  • 荷尔蒙疗法
  • 其他适应症
  • 全球粘膜给药设备市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 学术研究机构
  • 製药和生物技术公司
  • 诊断实验室
  • 医院
  • 全球粘膜给药装置市场：依类型细分：被动经皮给药、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 水库系统
  • 矩阵系统
  • 微针系统
  • 压敏胶黏剂体系
  • 全球粘膜给药装置市场：依主动经皮给药类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 离子电渗
  • 超音波导入
  • 电穿孔
  • 热消融
  • 微孔化

第七章 区域和国家分析

  • 全球粘膜给药装置市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球粘膜给药装置市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 粘膜给药装置市场：竞争格局
  • 粘膜给药装置市场：公司简介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Novartis AG
  • Becton Dickinson and Company
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • AptarGroup
  • Glenmark Pharmaceuticals Limited
  • Stevanato Group SpA
  • Lifevision Healthcare Private Limited
  • Noven Pharmaceuticals
  • SAVA Healthcare Limited
  • Antares Pharma Inc.
  • Kaizen Pharmaceuticals Pvt. Ltd.
  • Lucky Pharma Pvt. Ltd.
  • Maya Biotech Pvt. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年粘膜给药装置市场：提供新机会的国家
  • 2029年粘膜给药设备市场：细分市场带来新机会
  • 2029年粘膜给药装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r31415u

Transmucosal drug delivery devices are medical instruments designed to administer drugs through mucous membranes, such as those found in the mouth, nose, or rectum, allowing for rapid absorption into the bloodstream. These devices are particularly useful for delivering medications that are poorly absorbed by the gastrointestinal tract or require swift onset of action, such as pain relief or hormone therapy. Their primary function is to circumvent the digestive system, offering a direct and efficient route for drug delivery.

The two main categories of transmucosal drug delivery devices are passive transmucosal drug delivery and active transmucosal drug delivery. Passive transmucosal drug delivery involves the absorption of drugs through mucous membranes without external energy or active transport mechanisms. Various types of products include buccal tablets, oral sprays, sublingual films, wafers, gels, medicated confectionery, among others, used for treating conditions such as pain management, addiction, and hormonal therapies. End users include academic and research institutions, pharmaceutical and biotechnology firms, diagnostic laboratories, and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The transmucosal drug delivery devices research report is one of a series of new reports from The Business Research Company that provides transmucosal drug delivery devices market statistics, including the transmucosal drug delivery devices industry's global market size, regional shares, competitors with a transmucosal drug delivery devices market share, detailed transmucosal drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the transmucosal drug delivery devices industry. This transmucosal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $50.24 billion in 2024 to $54.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins.

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $76.06 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations.

The forecast of 8.6% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for bioadhesive polymer films and precision dosing pumps, sourced from key regions such as Belgium and Canada, could lead to shortages in rapid-acting medication systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of chronic diseases is expected to drive the growth of the transmucosal drug delivery devices market in the coming years. Chronic diseases are long-lasting conditions that typically develop gradually and persist over time, often requiring ongoing medical management to control symptoms and prevent complications. The rise in chronic diseases can be attributed to factors such as lifestyle choices, aging populations, environmental influences, challenges within healthcare systems, and urbanization. Transmucosal drug delivery devices are employed in managing chronic diseases by providing controlled and efficient medication delivery, ensuring sustained therapeutic levels to manage symptoms and enhance patient adherence. For example, in August 2023, a report from the Leukemia & Lymphoma Society (LLS), a US-based nonprofit organization, indicated that in the US, a person is diagnosed with leukemia, lymphoma, or myeloma approximately every three minutes. In 2023, an estimated 184,720 individuals were expected to be diagnosed, accounting for 9.4% of the projected 1,958,310 new cancer cases for the year. Therefore, the rising prevalence of chronic diseases is fueling the growth of the transmucosal drug delivery devices market.

Leading companies in the transmucosal drug delivery devices sector are actively pursuing innovative solutions such as proprietary transdermal patch delivery platforms, which are designed to improve drug absorption, enhance patient compliance, and offer convenience. These platforms utilize specialized technologies owned by companies to administer medications through the skin, ensuring controlled release and optimized therapeutic outcomes. For example, in January 2024, Starton Therapeutics Inc., a US-based biotechnology firm, introduced STARSILON, a novel proprietary transdermal patch delivery platform. This platform is specifically designed to deliver difficult-to-formulate active pharmaceutical ingredients (APIs) over an extended period, thereby expanding the options for transdermal drug delivery and enhancing therapeutic efficacy through sustained release mechanisms.

In April 2023, Difgen Pharmaceuticals, an India-based pharmaceutical company, acquired Aveva Drug Delivery Services for an undisclosed sum. This strategic acquisition is intended to bolster Difgen Pharmaceuticals' drug delivery capabilities and incorporate advanced technologies into its pharmaceutical product portfolio. Aveva Drug Delivery Services, based in the US, specializes in manufacturing transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transmucosal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transmucosal drug delivery devices market consists of sales of sublingual sprays, nasal drops, rectal suppositories, and sublingual tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transmucosal Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transmucosal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transmucosal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transmucosal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Passive Transdermal Drug Delivery; Active Transdermal Drug Delivery
  • 2) By Drug Type: Buccal Tablets; Oral Sprays; Sublingual Films And Wafers; Gels; Medicated Confectionery; Other Drug Types
  • 3) By Indication: Pain Management; Addiction Treatment; Hormonal Therapies; Others Indications
  • 4) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Hospitals
  • Subsegments:
  • 1) By Passive Transdermal Drug Delivery: Reservoir Systems; Matrix Systems; Micro-Needle Systems; Pressure-Sensitive Adhesive Systems
  • 2) By Active Transdermal Drug Delivery: Iontophoresis; Sonophoresis; Electroporation; Thermal Ablation; Microporation
  • Companies Mentioned: Johnson & Johnson; Bayer AG; Sanofi SA; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG; Becton Dickinson and Company; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Catalent Inc.; AptarGroup; Glenmark Pharmaceuticals Limited; Stevanato Group S.p.A; Lifevision Healthcare Private Limited; Noven Pharmaceuticals; SAVA Healthcare Limited; Antares Pharma Inc.; Kaizen Pharmaceuticals Pvt. Ltd.; Lucky Pharma Pvt. Ltd.; Maya Biotech Pvt. Ltd; AdvaCare Pharma LLP; Satsuma Pharmaceuticals Inc.; Biophar Lifesciences Private Limited; Fibovil Pharmaceuticals Private Limited; Slan Medicinal Holdings Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transmucosal Drug Delivery Devices Market Characteristics

3. Transmucosal Drug Delivery Devices Market Trends And Strategies

4. Transmucosal Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Transmucosal Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transmucosal Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transmucosal Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Transmucosal Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transmucosal Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transmucosal Drug Delivery Devices Total Addressable Market (TAM)

6. Transmucosal Drug Delivery Devices Market Segmentation

  • 6.1. Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Passive Transdermal Drug Delivery
  • Active Transdermal Drug Delivery
  • 6.2. Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Tablets
  • Oral Sprays
  • Sublingual Films And Wafers
  • Gels
  • Medicated Confectionery
  • Other Drug Types
  • 6.3. Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Addiction Treatment
  • Hormonal Therapies
  • Other Indications
  • 6.4. Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals
  • 6.5. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Passive Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reservoir Systems
  • Matrix Systems
  • Micro-Needle Systems
  • Pressure-Sensitive Adhesive Systems
  • 6.6. Global Transmucosal Drug Delivery Devices Market, Sub-Segmentation Of Active Transdermal Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iontophoresis
  • Sonophoresis
  • Electroporation
  • Thermal Ablation
  • Microporation

7. Transmucosal Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transmucosal Drug Delivery Devices Market

  • 8.1. Asia-Pacific Transmucosal Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transmucosal Drug Delivery Devices Market

  • 9.1. China Transmucosal Drug Delivery Devices Market Overview
  • 9.2. China Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transmucosal Drug Delivery Devices Market

  • 10.1. India Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transmucosal Drug Delivery Devices Market

  • 11.1. Japan Transmucosal Drug Delivery Devices Market Overview
  • 11.2. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transmucosal Drug Delivery Devices Market

  • 12.1. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transmucosal Drug Delivery Devices Market

  • 13.1. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transmucosal Drug Delivery Devices Market

  • 14.1. South Korea Transmucosal Drug Delivery Devices Market Overview
  • 14.2. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transmucosal Drug Delivery Devices Market

  • 15.1. Western Europe Transmucosal Drug Delivery Devices Market Overview
  • 15.2. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transmucosal Drug Delivery Devices Market

  • 16.1. UK Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transmucosal Drug Delivery Devices Market

  • 17.1. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transmucosal Drug Delivery Devices Market

  • 18.1. France Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transmucosal Drug Delivery Devices Market

  • 19.1. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transmucosal Drug Delivery Devices Market

  • 20.1. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transmucosal Drug Delivery Devices Market

  • 21.1. Eastern Europe Transmucosal Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transmucosal Drug Delivery Devices Market

  • 22.1. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transmucosal Drug Delivery Devices Market

  • 23.1. North America Transmucosal Drug Delivery Devices Market Overview
  • 23.2. North America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transmucosal Drug Delivery Devices Market

  • 24.1. USA Transmucosal Drug Delivery Devices Market Overview
  • 24.2. USA Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transmucosal Drug Delivery Devices Market

  • 25.1. Canada Transmucosal Drug Delivery Devices Market Overview
  • 25.2. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transmucosal Drug Delivery Devices Market

  • 26.1. South America Transmucosal Drug Delivery Devices Market Overview
  • 26.2. South America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transmucosal Drug Delivery Devices Market

  • 27.1. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transmucosal Drug Delivery Devices Market

  • 28.1. Middle East Transmucosal Drug Delivery Devices Market Overview
  • 28.2. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transmucosal Drug Delivery Devices Market

  • 29.1. Africa Transmucosal Drug Delivery Devices Market Overview
  • 29.2. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transmucosal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Transmucosal Drug Delivery Devices Market Competitive Landscape
  • 30.2. Transmucosal Drug Delivery Devices Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Transmucosal Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Becton Dickinson and Company
  • 31.3. Viatris Inc.
  • 31.4. Teva Pharmaceutical Industries Ltd.
  • 31.5. Catalent Inc.
  • 31.6. AptarGroup
  • 31.7. Glenmark Pharmaceuticals Limited
  • 31.8. Stevanato Group S.p.A
  • 31.9. Lifevision Healthcare Private Limited
  • 31.10. Noven Pharmaceuticals
  • 31.11. SAVA Healthcare Limited
  • 31.12. Antares Pharma Inc.
  • 31.13. Kaizen Pharmaceuticals Pvt. Ltd.
  • 31.14. Lucky Pharma Pvt. Ltd.
  • 31.15. Maya Biotech Pvt. Ltd.

32. Global Transmucosal Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transmucosal Drug Delivery Devices Market

34. Recent Developments In The Transmucosal Drug Delivery Devices Market

35. Transmucosal Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Transmucosal Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transmucosal Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transmucosal Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer